Apogee Therapeutics Inc
APGE37.870USD
+0.930+2.52%
Close 08/26, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000Pre-market 08/27, 09:30 (ET)
2.22BMarket Cap
LossP/E TTM
Apogee Therapeutics Inc
37.870
+0.930+2.52%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-53.23%-48.48M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.30M
-199.67%-31.64M
---29.75M
---19.88M
---14.57M
---10.56M
--0.00
Net income from continuing operations
-72.43%-55.34M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
---31.73M
---20.84M
---18.89M
-190.94%-12.53M
---4.30M
Operating gains losses
613.79%207.00K
--76.00K
--48.00K
--36.00K
--29.00K
----
----
----
----
----
Other non-cash items
37.73%-1.52M
19.15%-2.23M
-1243.97%-3.12M
---2.76M
---2.44M
---2.75M
---232.00K
----
-100.00%0.00
--1.69M
Change in working capital
-124.60%-2.95M
-336.16%-5.96M
1290.10%3.73M
-51.84%1.54M
-289.19%-1.31M
--2.52M
---313.00K
--3.20M
-73.48%694.00K
--2.62M
-Change in prepaid expenses
161.22%895.00K
-196.60%-596.00K
-95.34%-2.81M
36.82%-1.21M
-3222.73%-1.46M
--617.00K
---1.44M
---1.92M
---44.00K
--0.00
-Change in other current assets
---6.84M
114.95%16.00K
---46.00K
---67.00K
----
---107.00K
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-53.23%-48.48M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.30M
-199.67%-31.64M
---29.75M
---19.88M
---14.57M
---10.56M
--0.00
Investing cash flow
Net cash from continuing investing activities
1129.91%4.32M
-100.60%-1.00K
--751.00K
--51.00K
--351.00K
--167.00K
----
----
----
----
Capital expenditures
1129.91%4.32M
----
--751.00K
--51.00K
--351.00K
--167.00K
----
----
----
----
Net cash flow from disposal of fixed assets
1129.91%4.32M
-100.60%-1.00K
--751.00K
--51.00K
--351.00K
--167.00K
----
----
----
----
Net cash flow from investment products
133.66%17.30M
217.31%46.37M
37.82%-145.63M
---148.66M
---51.39M
---39.52M
---234.22M
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
125.09%12.98M
216.82%46.37M
37.50%-146.38M
---148.71M
---51.74M
---39.69M
---234.22M
----
----
----
Financing cash flow
Cash flow from continuous financing activities
-99.86%622.00K
20924.41%44.36M
-99.88%383.00K
91.15%-150.00K
--450.52M
---213.00K
--317.30M
---1.69M
-100.00%0.00
--5.00M
Net cash flow from common stock issuance/repurchase
-100.00%0.00
--43.53M
-100.00%0.00
---541.00K
--450.50M
----
--315.60M
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
--5.00M
Proceeds from stock option exercised by employees
2491.67%622.00K
--828.00K
--383.00K
--391.00K
--24.00K
----
----
----
----
----
Net cash flow from other financing activities
----
----
----
----
----
----
--1.69M
---1.69M
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-99.86%622.00K
20924.41%44.36M
-99.88%383.00K
91.15%-150.00K
--450.52M
---213.00K
--317.30M
---1.69M
-100.00%0.00
--5.00M
Net cash flow
Beginning cash balance
19.79%142.08M
-36.75%119.07M
145.94%307.59M
243.69%485.75M
-21.91%118.61M
--188.27M
--125.07M
--141.33M
--151.89M
--0.00
Current period cash flow changes
-109.50%-34.87M
133.03%23.01M
-398.29%-188.52M
-995.41%-178.16M
3577.70%367.14M
---69.66M
--63.20M
---16.26M
-311.14%-10.56M
--5.00M
Ending cash balance
-77.93%107.21M
19.79%142.08M
-36.75%119.07M
145.94%307.59M
243.69%485.75M
--118.61M
--188.27M
--125.07M
2726.66%141.33M
--5.00M
Free cash flow
-65.05%-52.79M
----
-117.68%-43.27M
---29.35M
---31.99M
---29.92M
---19.88M
----
----
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
